Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceutical ingredients Evonik Sells U.K. Site to ManagementAsahi Kasei to Expand Rechargeable Battery Separators Production CapacityTata Chemicals to Invest in Singapore Seedling Firm to Boost Biofuels ProgramJohnson Matthey Completes Sale of Ceramic Insulator and Alumina BusinessesCW's Asia Chemical Prices for the Week Ended November 25, 2008 Related Stories Indian Pharma Firm to Spin off Generics and IngredientsGlenmark Buys Czech Pharma FirmIndian Firm is First to Join USP Verification ProgramIPS Opens Two Service Offices in IndiaAlembic Completes Acquisition of Dabur Pharma

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

April 28, 2008

Fresenius Kabi Buys Indian Generics and API Firm

Deepti Ramesh

Fresenius Kabi (Bad Homburg, Germany), a unit of health care group Fresenius SE, says it has acquired 73.3% stake in Dabur Pharma (New Delhi) for about €139 million ($224 million). Fresenius Kabi says it has also offered to acquire a further 20% stake in...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers